We asked scientists, entrepreneurs, and activists why the time was right for open source pharmaceuticals.
​Click on the authors below to read what they had to say.

​BY JAMES ARINAITWE

Global Health Corps & Aspen Institute Fellow / Kampala​
​

BY JOHN WILBANKS

​Chief Commons Officer of Sage Bionetworks / Washington, D.C.
​

BY ELS TORREELE

​DirECTOR of Access to Essential Medicines Initiative, Open Society Foundations / NYC

​ BY MANICA BALesEGARAM
​
ExecUTIVE Director, Access Campaign, Médecins Sans Frontières / Geneva​
​

BY DIMITRIOS TZALIS
​
Founder & CEO of Taros Chemicals / Dortmund
​
​

BY TOMASZ SABLINSKI

CEO of Transparency Life Sciences / NYC​
​
​

BY MATTHEW TODD

​Founder of Open Source Malaria / Sydney & Cambridge
​

BY POLLY J. PRICE 

Emory University law professor / Atlanta​
​
​

BY T.V MOHANDIS PAI

Chairman of Manipal Global Education Services / Bangalore​
​

BY ZAKIR THOMAS

​Open innovation expert & former Project Director of OSDD / Delhi
​

"Why we need Open Source Pharma -- voices from Atlanta to Delhi speak up"​
By Open Source Pharma on THUNDERCLAP

See article